ESR1 and breast cancer: Moreover, the SNP has not been associated with testosterone levels, making it suitable to estimate the independent effect of estradiol.13 Also, the SNP has been validated against known or suspected estradiol-related traits, such as bone mineral density and insulin sensitivity, as well as estrogen receptor positive breast cancer and endometrial cancer.13,29 Finally, MR estimates lifetime effects rather than acute effects.